Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin promoter polymorphisms and prognosis in colorectal cancer.

Carcinogenesis - 1 Jun 2008

Wilkening Stefan, Tavelin Björn, Canzian Federico, Enquist Kerstin, Palmqvist Richard, Altieri Andrea, Hallmans Göran, Hemminki Kari, Lenner Per, Försti Asta

Abstract excerpt

There is strong evidence that cancer-associated inflammation promotes tumor growth and progression. This is especially true for colorectal cancer (CRC). Interleukins (ILs) are important modulators for inflammation. We examined whether promoter polymorphisms in key IL genes (IL4, IL4R, IL6, IL8 and IL10) are associated with the risk or clinical outcome of CRC. Five single-nucleotide polymorphisms (SNPs) were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Interleukins

Share to Kaplan-Meier Estimate

Share to Polymerase Chain Reaction

Share to Prognosis

Share to Promoter Regions, Genetic

Source

Identifiers

PMID: 18448485
DOI: 10.1093/carcin/bgn101

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin promoter polymorphisms and prognosis in colorectal cancer.PMID 18448485Read ↗

Impact of interleukin-10 gene polymorphisms on survival in patients with colorectal cancer.Semantic proximity Read ↗

Cytokine gene polymorphisms, cancer susceptibility, and prognosis.Semantic proximity Read ↗

Interleukin-10 polymorphisms, cancer susceptibility and prognosis.Semantic proximity Read ↗

Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer.Semantic proximity Read ↗

Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.Semantic proximity Read ↗

Meta-analysis of epidemiological studies of association of two polymorphisms in the interleukin-10 gene promoter and colorectal cancer risk.Semantic proximity Read ↗

Interleukin genes and associations with colon and rectal cancer risk and overall survival.Semantic proximity Read ↗

The association of three promoter polymorphisms in interleukin-10 gene with the risk for colorectal cancer and hepatocellular carcinoma: A meta-analysis.Semantic proximity Read ↗

Significance of -1082A/G polymorphism of IL10 gene for progression of colorectal cancer and IL-10 expression.Semantic proximity Read ↗

Genetic Insights into Interleukin-13 Polymorphisms in Colorectal Cancer Risk and Progression.Semantic proximity Read ↗

The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.Semantic proximity Read ↗

Inflammatory breast cancer: High incidence of GCC haplotypes (-1082A/G, -819T/C, and -592A/C) in the interleukin-10 gene promoter correlates with over-expression of interleukin-10 in patients' carcinoma tissues.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.